Date/Time
Date(s) - 14/06/2023
6:00 pm - 7:30 pm

Categories No Categories

Recent developments have shown the potential for the use of AI in the early detection of diseases such as cancer, Alzheimer’s and retinal diseases. What is the current state of this technology? What will this mean for clinicians and patients? What are the ethical implications? How do we regulate this rapidly evolving technology? These are just some of the questions that we hope to explore at this discussion event.

The event will be chaired by Rt Hon the Lord (David) Willetts FRS.

Speakers:

• David Crosby, Head of Early Detection Research, Cancer Research UK
• Lisa Farier, Head of Research Informatics , Alzheimer’s Research UK
• Jessica Morely, Bennett Unit for Applied Science, University of Oxford

To register, click here.

Note that this event also has in-person attendees. If you would prefer to attend the event in-person instead (at the Royal Society in London), then please email office@foundation.org.uk.

This event has been kindly supported by the Compound Semiconductor Applications Catapult, Coherent, and Techworks-NMI.